Emerging Infectious Diseases (Jun 2021)

Neurologic Disease after Yellow Fever Vaccination, São Paulo, Brazil, 2017–2018

  • Ana Freitas Ribeiro,
  • Bruno Fukelmann Guedes,
  • Jamal M.A.H. Sulleiman,
  • Francisco Tomaz Meneses de Oliveira,
  • Izabel Oliva Marcilio de Souza,
  • Juliana Silva Nogueira,
  • Rosa Maria Nascimento Marcusso,
  • Eder Gatti Fernandes,
  • Guilherme Sciascia do Olival,
  • Pedro Henrique Fonseca Moreira de Figueiredo,
  • Ana Paula Rocha Veiga,
  • Flávia Esper Dahy,
  • Natália Nasser Ximenes,
  • Lecio Figueira Pinto,
  • José Ernesto Vidal,
  • Augusto Cesar Penalva de Oliveira

DOI
https://doi.org/10.3201/eid2706.204170
Journal volume & issue
Vol. 27, no. 6
pp. 1577 – 1587

Abstract

Read online

Yellow fever (YF) vaccine can cause neurologic complications. We examined YF vaccine–associated neurologic disease reported from 3 tertiary referral centers in São Paulo, Brazil, during 2017–2018 and compared the performance of criteria established by the Yellow Fever Vaccine Working Group/Centers for Disease Control and Prevention and the Brighton Collaboration. Among 50 patients who met inclusion criteria, 32 had meningoencephalitis (14 with reactive YF IgM in cerebrospinal fluid), 2 died, and 1 may have transmitted infection to an infant through breast milk. Of 7 cases of autoimmune neurologic disease after YF vaccination, 2 were acute disseminated encephalomyelitis, 2 myelitis, and 3 Guillain-Barré syndrome. Neurologic disease can follow fractional vaccine doses, and novel potential vaccine-associated syndromes include autoimmune encephalitis, opsoclonus-myoclonus-ataxia syndrome, optic neuritis, and ataxia. Although the Brighton Collaboration criteria lack direct vaccine causal assessment, they are more inclusive than the Centers for Disease Control and Prevention criteria.

Keywords